Wealthier Towns Kept Breast Cancer Screening Alive During COVID-19, Nationwide Japanese Analysis Finds

When the COVID-19 pandemic swept across the world in 2020, one of its quieter casualties was the routine cancer screening appointment. Lockdowns, overwhelmed clinics, and public fear of contagion combined to keep millions of people away from preventive care. Now, a nationwide analysis from Japan has revealed just how unevenly that disruption fell, showing that the economic strength of a local community played a decisive role in whether women continued to receive mammograms during the first year of the crisis.

The study, led by Noriaki Takahashi of the International University of Health and Welfare and the National Cancer Center Institute for Cancer Control, together with colleagues including Mutsuhiro Nakao, Hirokazu Takahashi, Tomio Nakayama, and Tsutomu Yamazaki, was published as an open-access research paper in the journal Discover Social Science and Health. It examined breast cancer screening participation across 1,707 Japanese municipalities, offering one of the most comprehensive pictures to date of how a public health emergency reshaped preventive cancer care in the Western Pacific region, where such data had previously been scarce.

The research team designed the investigation as an ecological study, a type of epidemiological analysis that examines populations rather than individuals. Their central question was deceptively simple: which characteristics of a municipality predicted whether its breast cancer screening participation rate held up between 2019 and 2020? To answer it, they calculated a ratio comparing each municipality’s 2020 screening participation rate with its 2019 rate. A ratio close to one meant participation had remained stable, while a lower ratio signaled a sharper decline during the pandemic’s turbulent first year.

Against this measure, the researchers tested twelve municipality-level factors spanning three broad domains: population characteristics, local government finances, and medical resources. These included measures such as population density, per capita municipal expenditure, the ratio of hospitals to residents, and the local unemployment rate. To handle the statistical quirks of municipal data, which can be heavily skewed by tiny villages and sprawling metropolises alike, the team applied a rank-based inverse-normal transformation to the variables, a technique that converts raw values into a standard normal distribution while preserving their rank order.

The analytical strategy proceeded in two stages. First, correlation analyses identified which of the twelve factors were individually associated with changes in screening participation. Then, a multiple linear regression model incorporated all the independent variables simultaneously, allowing the researchers to isolate the effect of each factor while accounting for the others. The team also checked for multicollinearity using variance inflation factors, a standard diagnostic that flags when predictor variables are so closely related that they distort one another’s estimated effects. Statistical significance was set at a two-sided p value below 0.05.

The final model distilled the twelve candidate factors down to four that independently predicted how well a municipality’s screening program weathered the pandemic: population density, annual municipal expenditure per capita, the hospital ratio, and the unemployment rate. Two of these stood out with particular clarity. Annual municipal expenditure per capita showed a positive association with the change in participation, with a standardized coefficient of 0.188 and a p value below 0.001, meaning that towns and cities that spent more per resident were significantly more likely to maintain screening attendance. Conversely, the unemployment rate was negatively associated with the change, with a coefficient of −0.081 and a p value of 0.007, indicating that communities with higher joblessness suffered steeper drops in participation.

These two findings point toward a unifying interpretation: regional economic status is a key determinant of whether preventive cancer screening survives a public health emergency. Municipalities with deeper financial reserves could presumably keep screening programs running, communicate with residents, and provide the logistical support that encourages attendance, even as infection control measures strained every corner of the healthcare system. Meanwhile, communities already facing economic precarity, where residents may be juggling job insecurity and reduced access to care, saw the fabric of routine prevention fray more quickly.

The implications reach well beyond Japan’s borders. Many countries, particularly those with decentralized health systems, deliver organized cancer screening through local administrations rather than national programs. The Japanese experience suggests that during a crisis, the resilience of these local programs depends heavily on their funding base and the economic conditions of the populations they serve. If screening participation collapses unevenly, the pandemic’s indirect toll on cancer mortality may be concentrated in already disadvantaged areas, widening health disparities that persist long after the acute emergency fades.

Breast cancer remains one of the most common malignancies affecting women worldwide, and organized mammography screening is a cornerstone of early detection, catching tumors at stages when treatment is most effective. A temporary dip in participation may seem trivial, but screening programs operate on the arithmetic of population coverage: every percentage point of lost attendance translates into missed diagnoses, later-stage tumors, and, ultimately, preventable deaths. The Japanese data provide a quantitative warning that the pandemic’s disruption of screening was not a uniform shock but a differentiated one, mediated by the socioeconomic texture of each community.

The authors conclude that addressing disparities in screening participation requires attention to how public health services are funded and provided, particularly in preparation for future emergencies. Their findings, supported by a Health and Labour Sciences Research Grant from Japan’s Ministry of Health, Labour and Welfare, offer a data-driven blueprint for policymakers: strengthening the financial capacity of municipal screening programs and targeting support to economically struggling communities could make preventive cancer care more resilient the next time a crisis strikes. As the world absorbs the lessons of COVID-19, this nationwide analysis makes a compelling case that protecting routine prevention is not merely a medical logistics problem but a question of economic equity, decided in the budgets of town halls and the paychecks of ordinary residents.

Subject of Research: Municipal socioeconomic and healthcare factors influencing breast cancer screening participation during the COVID-19 pandemic in Japan

Article Title: A nationwide ecological analysis of municipal factors affecting breast cancer screening participation during the COVID-19 pandemic in Japan

Article References: Takahashi, N., Nakao, M., Takahashi, H., Nakayama, T., & Yamazaki, T. (2026). A nationwide ecological analysis of municipal factors affecting breast cancer screening participation during the COVID-19 pandemic in Japan. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00460-0

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00460-0

Keywords: breast cancer screening, COVID-19, Japan, municipal finances, health disparities, ecological study, mammography, unemployment, population density, public health emergency, preventive care, health policy